Employees
64
Industry
Pharmaceutical Preparation Manufacturing
mpm is an early-stage life sciences venture investing firm with a track record of identifying and building world-class companies that seek to cure major diseases by translating scientific innovations into positive clinical outcomes. mpm’s portfolio of companies aims to revolutionize the face of medicine across multiple areas including cancer, neuroscience, metabolic disorders, and regenerative medicine. with its deep experience, dedicated team of operating executives, and distinguished medical and scientific advisory board, mpm is powering novel medical breakthroughs that transform patient lives.
Loading...
Open
0.13
Mkt cap
N/A
Volume
136K
High
0.20
P/E Ratio
-0.04
52-wk high
0.47
Low
0.13
Div yield
1.11
52-wk low
0.01
Portfolio Pulse from Benzinga Insights
June 14, 2023 | 1:08 pm
Portfolio Pulse from Lisa Levin
June 14, 2023 | 12:07 pm
Portfolio Pulse from Lisa Levin
June 12, 2023 | 6:54 pm
Portfolio Pulse from Lisa Levin
June 12, 2023 | 5:04 pm
Portfolio Pulse from Lisa Levin
June 12, 2023 | 4:05 pm
Portfolio Pulse from Benzinga Insights
June 12, 2023 | 1:07 pm
Portfolio Pulse from Lisa Levin
June 12, 2023 | 12:24 pm
Portfolio Pulse from Benzinga Newsdesk
June 12, 2023 | 10:34 am
Portfolio Pulse from Happy Mohamed
June 09, 2023 | 8:30 pm
Portfolio Pulse from Lisa Levin
June 08, 2023 | 12:23 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.